P. Wen

Molecular Biology · 2006–2018

A researcher in the Science corpus: 16 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom P. Wen trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Rakesh K. Jain
  2. D. Louis
  3. G. Bergers

Who trusts P. Wen overall

  1. Jason T. Huse
  2. P. Delgado-López
  3. Michael Weller
  4. Eric C. Holland

Papers from P. Wen's perspective

Ordered by how strongly the researchers P. Wen trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. (New England Journal of Medicine)
  2. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy (Science)
  3. AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. (Cancer Cell)
  4. Pathophysiological consequences of VEGF-induced vascular permeability (Nature)
  5. Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy (Nature Medicine)
  6. Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors (Cancer Research)
  7. The biology of VEGF and its receptors (Nature Medicine)
  8. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. (New England Journal of Medicine)
  9. Modes of resistance to anti-angiogenic therapy (Nature Reviews. Cancer)
  10. An Integrated Genomic Analysis of Human Glioblastoma Multiforme (Science)

Their papers